CD27 CHO-K1 Stable Recombinant Cell Line

Catalog #
60624
$4,500 *
Size: 2 vials
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

CHO-K1 cell line expressing full length human CD27 (TNFRSF7). Expression is confirmed by real time qPCR, Western blot, and flow cytometry.

Screening for antibodies recognizing CD27 and screening antibodies for binding affinities. Since
CHO-K1 cells do not express endogenous CD27, this cell line serves as an excellent model for
studying changes in CD27-mediated signaling pathways, such as NF-kB, MAPK and
SAPK/JNK.

Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.

Synonyms
CD70 antigen, Tumor Necrosis Factor Ligand Superfamily Member 7, TNFSF7, CD27 Ligand, Ki-24 antigen, CD27-L, CD27LG,
Product Info
Storage and Usage
Citations
Host Cell Line
CHO-K1
Supplied As
Each vial contains ~2 X 106 cells in 1 ml of 10% DMSO.
Format
Aqueous solution containing DMSO
UniProt #
P26842
Mycoplasma Testing
This cell line has been screened using the MycoAlert™ Mycoplasma Detection Kit (Lonza, Cat. #LT07-118) to confirm the absence of Mycoplasma contamination. MycoAlert Assay Control Set (Lonza, Cat. #LT07-518) was used as a positive control.
Background
CD27 is a member of the tumor necrosis factor (TNF) receptor superfamily, which includes the T cell co-stimulatory receptors OX40, 4-1BB and herpesvirus entry mediator (HVEM). CD27 is expressed on various types of T cells, B cells and a subset of natural killer cells. It activates NF- kB and MAPK/JNK signaling upon interaction with its TNF-like ligand, CD70, which is expressed by numerous tumor cells. Adaptor proteins TRAF2 and TRAF5 can also stimulate CD27 signaling. Activation of CD27 leads to lymphoid proliferation, differentiation, apoptosis, and the induction of long-term memory. The CD27/CD70 pathway is a key target for the development of treatments for cancer and inflammatory diseases.
References

1. Akiba H et.al. (1998) CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kB and stress-activated protein kinase/ c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kB inducing kinase. J. Biol. Chem.  273: 13353

2. Yamamoto H et.al. (1998) NF-kB activation in CD27 signaling: Involvement of TNF receptor-associated factor in its signaling and identification of functional region of CD27. J. Immunology  161: 4753-4759